Trials of Treatment Deescalati... Note

Trials of Treatment Deescalation, Deimplementation, and Discontinuation

To the Editor As therapeutic options expand and polypharmacy and drug-related harms become increasingly common, evidence-based treatment discontinuation is becoming an important clinical priority. Dr Huang and colleagues’ timely overview of deescalation and discontinuation trials raised a fundamental methodological question: what exactly do these trials estimate?